However, we have shown that B55 KD dramatically reduces TNBC metastasis without significant adverse effects in mice (27), suggesting that inhibiting the PP2A–B55 function will likely have a therapeutic window for breast cancer. The gene discussed is PPP2R2A; the disease is breast cancer.